Both in Pharmaceuticals
Journey Medical vs Minerva Neurosciences
Over the past year DERM returned −45.5% and NERV returned −38.5%; their daily moves had a correlation of 0.14.
DERM −45.5% NERV −38.5%Growth of $1, one year, split-adjusted
| Metric | DERM | NERV |
|---|---|---|
| Price | $4.64 | $2.35 |
| Market cap | $131.0M | $112.2M |
| Today | −3.13% | +0.21% |
| 1 month | −30.6% | −29.2% |
| 6 months | −10.4% | −62.4% |
| Year to date | −39.8% | −41.5% |
| 1 year | −42.9% | −44.0% |
| Revenue growth (YoY) | +18.9% | — |
| Gross margin | 65.6% | — |
| Net margin | −1.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | — |
| Net cash | -$245.0K | $75.3M |
| Dividend yield | — | — |
| Volatility (60d) | 64.3% | 78.0% |
| Short % of float | 24.8% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).